跳至主要内容
临床试验/NCT07113808
NCT07113808招募中不适用

Clinical Medical Quality Control Management of Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China: A Multi-Center Study

The Children's Hospital of Zhejiang University School of Medicine1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2024年9月10日最近更新:
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
108
试验地点
1
主要终点
sensitivity

研究概览

简要总结

The goal of this clinical trial is to evaluate the application of intravenous contrast-enhanced ultrasound examination in children with intra-abdominal diseases that require clear diagnoses. The main questions it aims to answer are:

  • Is intravenous contrast-enhanced ultrasound helpful for the diagnosis of intra-abdominal diseases in children?
  • What medical problems do participants have when participating in intravenous contrast-enhanced ultrasound examination?
  • How can ultrasound doctors conduct intravenous contrast-enhanced ultrasound examinations in a standardized manner? Researchers will performing intravenous contrast-enhanced ultrasound examinations on participants and collecting research subjects to establish a multicenter clinical data database.

Participants will:

  • Perform abdominal ultrasound examination to assess the condition.
  • At least conduct one intravenous contrast-enhanced ultrasound examination. Based on the result of the contrast examination, decide whether to conduct another examination.
  • Keep a diary of their symptoms and therapeutic process in 30 days.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
29 Days 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 29 days to 18 years old;
  • The clinical diagnosis was abdominal space-occupying lesions, blunt abdominal trauma, ascites of unknown cause, and children with suspected abdominal disease but other examinations could not identify the cause.

排除标准

  • Allergic to sulfur hexafluoride or other components;
  • Heart disease with right-to-left shunt/severe pulmonary hypertension /uncontrolled systemic hypertension/respiratory failure/heart failure/severe arrhythmia;
  • Electrocardiogram, echocardiography or clinical manifestations of myocardial ischemia;
  • Patients with severe blood system diseases or infectious diseases;
  • Hypercoagulable state and recent history of thrombosis;
  • Severe hepatic and renal insufficiency;
  • Patients with respiratory tract infection or congenital respiratory malformation.

结局指标

主要结局

sensitivity

时间窗: Thirty days after the last venous ultrasound contrast examination

to calculate the sensitivity of venous contrast-enhanced ultrasound examination in children

specificity

时间窗: Thirty days after the last venous ultrasound contrast examination

to calculate the specificity of venous contrast-enhanced ultrasound examination in children

Positive predictive value

时间窗: Thirty days after the last venous ultrasound contrast examination

to calculate the positive predictive value of venous contrast-enhanced ultrasound examination in children

Negative predictive value

时间窗: Thirty days after the last venous ultrasound contrast examination

to calculate the negative predictive value of venous contrast-enhanced ultrasound examination in children

次要结局

未报告次要终点

研究者

发起方
The Children's Hospital of Zhejiang University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jingjing Ye

Director of the Ultrasound Department

The Children's Hospital of Zhejiang University School of Medicine

研究点 (1)

Loading locations...

相似试验